ORGANON & CO. (OGN)
Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada
Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada
📈 **POSITIVE** • High confidence analysis (89%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business